A crack in the spinning spiros ref# (b)(4) was evident in a hazardous sterile compounding preparation of an azacitidine drawn in a syringe, to be administered subcutaneously to a patient.This crack appears to be running almost the length of the spinning spiros.When pressure is applied to the syringe plunger, the hd medication sprays out through this crack.Medication was discarded as per the facility's medication waste disposal policy and a new csp was prepared for administration.Fda safety report id# (b)(4).
|